Gene · 4773
Papers3,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
781 to 800 of 3,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The TWEAK/Fn14/CD163 axis-implications for metabolic disease. | Rev Endocr Metab Disord | 2022 | 34542797 | PubTator, text mining | PubMed |
| Thioredoxin-Interacting Protein in Cancer and Diabetes. | Antioxid Redox Signal | 2022 | 34384271 | PubTator, text mining | PubMed |
| Association between nuclear factor of activated T cells C2 polymorphisms and treatment response in rheumatoid arthritis patients receiving tumor necrosis factor-alpha inhibitors. | Pharmacogenet Genomics | 2022 | 34320607 | PubTator, text mining | PubMed |
| Systematic review of human post-mortem immunohistochemical studies and bioinformatics analyses unveil the complexity of astrocyte reaction in Alzheimer's disease. | Neuropathol Appl Neurobiol | 2022 | 34297416 | PubTator, text mining | PubMed |
| Neuroimmune regulatory networks of the airway mucosa in allergic inflammatory disease. | J Leukoc Biol | 2022 | 33857344 | PubTator, text mining | PubMed |
| Differentially methylated regions within lung cancer risk loci are enriched in deregulated enhancers. | Epigenetics | 2022 | 33595421 | PubTator, text mining | PubMed |
| Alterations in the Ca2+ toolkit in oesophageal adenocarcinoma. | Explor Target Antitumor Ther | 2021 | 36046118 | PubTator, text mining | PubMed |
| RUNX inhibitor suppresses graft-versus-host disease through targeting RUNX-NFATC2 axis. | EJHaem | 2021 | 35844683 | PubTator, text mining | PubMed |
| Tumor-infiltrating T-regulatory cells adapt to altered metabolism to promote tumor-immune escape. | Curr Res Immunol | 2021 | 35492399 | PubTator, text mining | PubMed |
| miRNA-mediated alteration of sulfatase modifying factor 1 expression using self-assembled branched DNA nanostructures. | RSC Adv | 2021 | 35423539 | PubTator, text mining | PubMed |
| Computational System Level Approaches for Discerning Reciprocal Regulation of IL10 and IL12 in Leishmaniasis. | Front Genet | 2021 | 35126456 | PubTator, text mining | PubMed |
| Inhibition of Orai Channel Function Regulates Mas-Related G Protein-Coupled Receptor-Mediated Responses in Mast Cells. | Front Immunol | 2021 | 35126366 | PubTator, text mining | PubMed |
| TGF-β1 Drives Inflammatory Th Cell But Not Treg Cell Compartment Upon Allergen Exposure. | Front Immunol | 2021 | 35069535 | PubTator, text mining | PubMed |
| Peripheral-type primitive neuroectodermal tumor of the ovary with EWSR1-FLI1 fusion transcript: a case report and brief review of literature. | Rom J Morphol Embryol | 2021 | 35024748 | PubTator, text mining | PubMed |
| The Important Role of Ion Transport System in Cervical Cancer. | Int J Mol Sci | 2021 | 35008759 | PubTator, text mining | PubMed |
| Orai2 Modulates Store-Operated Ca2+ Entry and Cell Cycle Progression in Breast Cancer Cells. | Cancers (Basel) | 2021 | 35008277 | PubTator, text mining | PubMed |
| Coronin 6 promotes hepatocellular carcinoma progression by enhancing canonical Wnt/beta-catenin signaling pathway. | J Cancer | 2021 | 35003366 | PubTator, text mining | PubMed |
| Inflammatory Cell Composition and Immune-Related microRNA Signature of Temporal Artery Biopsies From Patients With Giant Cell Arteritis. | Front Immunol | 2021 | 35003111 | PubTator, text mining | PubMed |
| A Pilot Study on Early-Onset Schizophrenia Reveals the Implication of Wnt, Cadherin and Cholecystokinin Receptor Signaling in Its Pathophysiology. | Front Genet | 2021 | 34976023 | PubTator, text mining | PubMed |
| The Role of hsa-miR-21 and Its Target Genes Involved in Nasopharyngeal Carcinoma. | Asian Pac J Cancer Prev | 2021 | 34967592 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4773/papers?page=40